This HTML5 document contains 94 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38203964
rdf:type
wikibase:Item
schema:description
vedecký článok artículu científicu espublizáu en 2014 vetenskaplig artikel vitenskapelig artikkel artículo científico наукова стаття, опублікована у квітні 2014 scienca artikolo article científic مقالة علمية نشرت في 08 أبريل 2014 wetenschappelijk artikel vědecký článek articolo scientifico wissenschaftlicher Artikel artigo científico научни чланак বৈজ্ঞানিক নিবন্ধ artikull shkencor מאמר מדעי videnskabelig artikel article scientifique scientific article published on 08 April 2014 artigo científico научная статья scientific article published on 08 April 2014 articol științific bilimsel makale artigo científico scientific article published on 08 April 2014 vitskapeleg artikkel artikel ilmiah
p:P577
wds:Q38203964-E1F3253F-3786-4946-AB4F-69888F81AD20
wdt:P577
2014-04-08T00:00:00Z
p:P2093
wds:Q38203964-2C50F1C9-5A21-4E98-B0EB-6604D546692F wds:Q38203964-430D310B-9812-49EB-8185-7D2EB524D315 wds:Q38203964-4778E465-9D5E-4E9D-81A9-1732E8316F47 wds:Q38203964-3C58BF78-DB1C-4174-B83C-B4B07F60D215 wds:Q38203964-593C77F9-FCE4-49F5-93B6-43ECC635A5C0 wds:Q38203964-62D3CAA5-2A35-4BCC-9603-0E5F8C9F7E72 wds:Q38203964-4B4490DA-4CD1-4A0E-AFA4-D67A31AA4958 wds:Q38203964-6417656E-3E56-4D61-B588-1ED65723B656 wds:Q38203964-CBBD2D32-1EB4-4C88-8982-9EE773C59D20 wds:Q38203964-9B6C842F-CF7D-4C60-A1B7-BE9FBFD303C3 wds:Q38203964-FCBF8FA6-DDBF-4A5F-A3ED-D34B701C97D1 wds:Q38203964-D766F808-E3E9-4BAF-9817-DFEAEB2F40E6 wds:Q38203964-E1D7F2D5-FC0D-40CB-8B42-7C66C22F077C
wdt:P2093
Antoine Angelergues Nicolas Delanoy Mustafa Ozgüroglu Florence Mercier Gwenaelle Gravis Stéphane Oudard Sylvestre Le Moulec Aline Guillot Thibault de La Motte Rouge Denis Maillet Aude Fléchon Christophe Massard Reza-Thierry Elaidi
rdfs:label
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
skos:prefLabel
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
schema:name
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
p:P50
wds:Q38203964-891F52C1-E075-480C-9A4C-893D1B38B510 wds:Q38203964-8DDE46DD-4CE8-4149-881D-E3E6315415BD wds:Q38203964-498E967A-7C9D-44A3-9C5A-9FBAC9E2BE0B
wdt:P50
wd:Q73569107 wd:Q85991352 wd:Q115467721
p:P1476
wds:Q38203964-91E40144-CA28-41FC-94D7-76C521C36662
wdt:P1476
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
p:P304
wds:Q38203964-109E6A5F-D360-4E62-9C42-4C603B979679
wdt:P304
1602-1609
p:P31
wds:Q38203964-3678988A-EC03-4B7F-816E-89786E3F0CBB
wdt:P31
wd:Q13442814
p:P921
wds:Q38203964-0F330B1B-B29F-48C7-A6C5-A96532E2F385
wdt:P921
wd:Q181257
p:P698
wds:Q38203964-053F6A5A-F9C1-468F-ABF5-117C507370FC
wdtn:P698
n11:24725337
wdt:P698
24725337
p:P1433
wds:Q38203964-97AC5445-CD4A-46EF-805C-030D46A2E71C
wdt:P1433
wd:Q332260
p:P433
wds:Q38203964-1F6FF7BE-F1A6-43A2-914B-C1BF440F8530
p:P478
wds:Q38203964-0CD667E8-D955-4B62-A2F3-F062618593EE
wdt:P433
9
wdt:P478
50
p:P356
wds:Q38203964-A7443CBA-1B5E-4F8E-A5AA-A8B329866B9F
wdtn:P356
n12:J.EJCA.2014.03.015
wdt:P356
10.1016/J.EJCA.2014.03.015